Kuros Biosciences AG (KURN.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH0325814116
Kuros Biosciences AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 75.00 m USD | 121.00 m USD |
| Gross profit | 62.00 m USD | 104.00 m USD |
| Operating income | 108,864.00 USD | 7.09 m USD |
| EBIT | -4.00 m USD | 7.00 m USD |
| Net income | -3.00 m USD | 2.00 m USD |
| Diluted EPS – continuing operations | -0.10 USD | 0.05 USD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
More stocks
- Jilin Expressway Co Ltd (601518.SS)
- Cendes Co Ltd Class A (300492.SZ)
- R&G PharmaStudies Co. Ltd. A (301333.SZ)
- Jaya Real Property Tbk (JRPT.JK)
- Ottogi (007310.KS)
- GFT Technologies (GFT.DE)
- Basler (BSL.DE)
- Jiangxi Black Cat Carbon Black (002068.SZ)
- Guangdong Hongjing Optoelectronic Technology Inc. (301479.SZ)
- Chengdu Bright Eye Hospital Co. Ltd. (301239.SZ)
- Chongqing Road & Bridge Co Ltd (600106.SS)
- Knight Therapeutics Inc (GUD.TO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.